Featured FARA News and Blogs
Reata Pharmaceuticals Announces
FDA Approval of SKYCLARYS™ (Omaveloxolone)
View the recently updated
Clinical Management Guidelines for Friedreich Ataxia
Available Now! FARA’s Annual Donor Impact Report
Biogen Acquires Reata Pharmaceuticals - An Update for the FA Community
Clinical Trials now Enrolling Volunteers Needed!
Activities & Events
- rideATAXIA Gainesville (Saturday, March 23, 2024)
- rideATAXIA Chicago (Sunday, July 21, 2024)